Longer-term (Up to 6 Years) Efficacy of Ofatumumab in People with Recently Diagnosed and Treatment-naive Relapsing Multiple Sclerosis

Authors
Category Primary study
JournalNeurology
Year 2024
This article has no abstract
Epistemonikos ID: c6ed54b9cbfcd56ecbf437462ce7b41623b9ef83
First added on: Feb 19, 2025